We have identified that EphA2 could interact with HCMV gH/gL complex, but not gB to promote cell-cell fusion, which may support the development of gH/gL vaccines or drugs targeting gH/gL to block the HCMV infection. This evidence concerns the gene EPHA2 and cytomegalovirus infection.